Abstract
Investigating a recently developed Cushing Syndrome, we diagnosed in a 47-year-old woman an ectopic ACTH syndrome due to a metastatic carcinoid tumor, most likely a thymic carcinoid tumor. Combined therapy with sandostatin and nizoral and later on with sandostatin, metopirone and orimeten, was not able to suppress the hypercortisolism. A few weeks after surgical adrenalectomy, clinical deterioration ensued, culminating in the patient's death 7 months after diagnosis.
MeSH terms
-
ACTH Syndrome, Ectopic / drug therapy
-
ACTH Syndrome, Ectopic / etiology*
-
Aminoglutethimide / therapeutic use
-
Antifungal Agents / therapeutic use
-
Antimetabolites / therapeutic use
-
Carcinoid Tumor / drug therapy
-
Carcinoid Tumor / metabolism*
-
Enzyme Inhibitors / therapeutic use
-
Fatal Outcome
-
Female
-
Hormones / therapeutic use
-
Humans
-
Ketoconazole / therapeutic use
-
Metyrapone / therapeutic use
-
Middle Aged
-
Octreotide / therapeutic use
-
Thymus Neoplasms / drug therapy
-
Thymus Neoplasms / metabolism*
Substances
-
Antifungal Agents
-
Antimetabolites
-
Enzyme Inhibitors
-
Hormones
-
Aminoglutethimide
-
Ketoconazole
-
Octreotide
-
Metyrapone